215 related articles for article (PubMed ID: 30818083)
1. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer.
Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Parizadeh SMR; Vojdani S; Ghandehari M; Ghazaghi A; Khazaei M; Shahidsales S; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
Int J Biochem Cell Biol; 2019 May; 110():75-83. PubMed ID: 30818083
[TBL] [Abstract][Full Text] [Related]
2. Targeting Colorectal Cancer Stem Cells as an Effective Treatment for Colorectal Cancer.
Ma YS; Li W; Liu Y; Shi Y; Lin QL; Fu D
Technol Cancer Res Treat; 2020; 19():1533033819892261. PubMed ID: 32748700
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cells and Molecular Biology Test in Colorectal Cancer: Therapeutic Implications.
Effendi-Ys R
Acta Med Indones; 2017 Oct; 49(4):351-359. PubMed ID: 29348387
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
[TBL] [Abstract][Full Text] [Related]
5. Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles.
Ning ST; Lee SY; Wei MF; Peng CL; Lin SY; Tsai MH; Lee PC; Shih YH; Lin CY; Luo TY; Shieh MJ
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17793-804. PubMed ID: 27348241
[TBL] [Abstract][Full Text] [Related]
6. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer defeating? Challenge accepted!
Di Franco S; Todaro M; Dieli F; Stassi G
Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs are important regulators of drug resistance in colorectal cancer.
Zhang Y; Wang J
Biol Chem; 2017 Jul; 398(8):929-938. PubMed ID: 28095367
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.
Liu X; Fu Q; Du Y; Yang Y; Cho WC
Curr Cancer Drug Targets; 2016; 16(9):738-754. PubMed ID: 26577538
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1
Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G
Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895
[TBL] [Abstract][Full Text] [Related]
12. Identification of Novel Molecules Targeting Cancer Stem Cells.
Benoit YD
Methods Mol Biol; 2018; 1765():333-347. PubMed ID: 29589319
[TBL] [Abstract][Full Text] [Related]
13. [Research Progress in the Therapeutic Strategy Based on Targeting at
Lung Cancer Stem Cell].
Lai H; Lin F; Chen N; Wen S; Hu X; Liu L
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):57-62. PubMed ID: 29357974
[TBL] [Abstract][Full Text] [Related]
14. Biomarker targeting of colorectal cancer stem cells.
Caparosa EM; Stem J; Snook AE; Waldman SA
Biomark Med; 2019 Aug; 13(11):891-894. PubMed ID: 31385523
[No Abstract] [Full Text] [Related]
15. UCN-01 enhances cytotoxicity of irinotecan in colorectal cancer stem-like cells by impairing DNA damage response.
Signore M; Buccarelli M; Pilozzi E; De Luca G; Cappellari M; Fanciulli M; Goeman F; Melucci E; Biffoni M; Ricci-Vitiani L
Oncotarget; 2016 Jul; 7(28):44113-44128. PubMed ID: 27286453
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
17. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
[TBL] [Abstract][Full Text] [Related]
18. Activin pathway enhances colorectal cancer stem cell self-renew and tumor progression.
Liu R; Wang JH; Xu C; Sun B; Kang SO
Biochem Biophys Res Commun; 2016 Oct; 479(4):715-720. PubMed ID: 27693580
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.
Qureshi-Baig K; Ullmann P; Haan S; Letellier E
Mol Cancer; 2017 Feb; 16(1):40. PubMed ID: 28209178
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer stem cell: a potential therapeutic target.
Tao H; Zhu Y
Clin Transl Oncol; 2011 Dec; 13(12):833-8. PubMed ID: 22126725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
